PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $634,000 | +174.5% | 18,524 | +42.3% | 0.02% | +325.0% |
| Q3 2021 | $231,000 | -85.1% | 13,015 | -62.4% | 0.00% | -85.7% |
| Q2 2021 | $1,554,000 | +26.0% | 34,620 | -27.3% | 0.03% | +33.3% |
| Q1 2021 | $1,233,000 | +48.0% | 47,620 | +15.3% | 0.02% | +40.0% |
| Q4 2020 | $833,000 | +3.0% | 41,301 | -0.2% | 0.02% | -37.5% |
| Q3 2020 | $809,000 | +129.2% | 41,400 | +107.0% | 0.02% | +41.2% |
| Q2 2020 | $353,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |